Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects

[1] Baillargeon JP(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-47

[2] Baillargeon JP(2005)Use of insulin sensitizers in polycystic ovarian syndrome Curr Opin Investig Drugs 6 1012-1022

[3] Iuorno MJ(2003)Insulin sensitizers for polycystic ovary syndrome Clin Obstet Gynecol 46 325-340

[4] Nestler JE(2003)Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome Metabolism 52 908-915

[5] Glueck CJ(2000)Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome Hum Reprod 15 785-789

[6] Papanna R(1997)Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications Semin Reprod Endocrinol 15 111-122

[7] Wang P(1989)Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1165-1174

[8] Goldenberg N(2002)Effects of Endocr Pract 8 417-423

[9] Sieve-Smith L(1999)- N Engl J Med 340 1314-1320

[10] Cibula D(1997)-inositol in lean women with the polycystic ovary syndrome Hum Reprod 12 2641-2648

[1] Baillargeon JP(2004)Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 41-47

[2] Baillargeon JP(2005)Use of insulin sensitizers in polycystic ovarian syndrome Curr Opin Investig Drugs 6 1012-1022

[3] Iuorno MJ(2003)Insulin sensitizers for polycystic ovary syndrome Clin Obstet Gynecol 46 325-340

[4] Nestler JE(2003)Incidence and treatment of metabolic syndrome in newly referred women with confirmed polycystic ovarian syndrome Metabolism 52 908-915

[5] Glueck CJ(2000)Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome Hum Reprod 15 785-789

[6] Papanna R(1997)Role of hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome, and its clinical implications Semin Reprod Endocrinol 15 111-122

[7] Wang P(1989)Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome Diabetes 38 1165-1174

[8] Goldenberg N(2002)Effects of Endocr Pract 8 417-423

[9] Sieve-Smith L(1999)- N Engl J Med 340 1314-1320

[10] Cibula D(1997)-inositol in lean women with the polycystic ovary syndrome Hum Reprod 12 2641-2648